Absence 0 7 0 7 O
of 8 10 8 10 O
clinically 11 21 11 21 B-chronic_disease
significant 22 33 22 33 I-chronic_disease
macular 34 41 34 41 I-chronic_disease
edema 42 47 42 47 I-chronic_disease
( 48 49 48 49 I-chronic_disease
CSME 49 53 49 53 I-chronic_disease
) 53 54 53 54 I-chronic_disease
in 55 57 55 57 O
the 58 61 58 61 O
study 62 67 62 67 O
eye 68 71 68 71 O
as 72 74 72 74 O
detected 75 83 75 83 O
by 84 86 84 86 O
clinical 87 95 87 95 O
exam 96 100 96 100 O

Active 0 6 101 107 O
proliferative 7 20 108 121 B-chronic_disease
diabetic 21 29 122 130 I-chronic_disease
retinopathy 30 41 131 142 I-chronic_disease
in 42 44 143 145 I-chronic_disease
the 45 48 146 149 I-chronic_disease
study 49 54 150 155 I-chronic_disease
eye 55 58 156 159 I-chronic_disease

Any 0 3 160 163 O
concurrent 4 14 164 174 O
intraocular 15 26 175 186 O
condition 27 36 187 196 O
in 37 39 197 199 O
the 40 43 200 203 O
study 44 49 204 209 O
eye 50 53 210 213 O
that 54 58 214 218 O
, 58 59 218 219 O
in 60 62 220 222 O
the 63 66 223 226 O
opinion 67 74 227 234 O
of 75 77 235 237 O
the 78 81 238 241 O
investigator 82 94 242 254 O
, 94 95 254 255 O
could 96 101 256 261 O
require 102 109 262 269 O
either 110 116 270 276 O
medical 117 124 277 284 O
or 125 127 285 287 O
surgical 128 136 288 296 B-treatment
intervention 137 149 297 309 I-treatment
during 150 156 310 316 O
the 157 160 317 320 O
90 161 163 321 323 B-upper_bound
day 164 167 324 327 I-upper_bound
study 168 173 328 333 O
period 174 180 334 340 O

Any 0 3 341 344 O
concurrent 4 14 345 355 O
ocular 15 21 356 362 B-chronic_disease
condition 22 31 363 372 I-chronic_disease
in 32 34 373 375 O
the 35 38 376 379 O
study 39 44 380 385 O
eye 45 48 386 389 O
which 49 54 390 395 O
, 54 55 395 396 O
in 56 58 397 399 O
the 59 62 400 403 O
opinion 63 70 404 411 O
of 71 73 412 414 O
the 74 77 415 418 O
investigator 78 90 419 431 O
, 90 91 431 432 O
could 92 97 433 438 O
either 98 104 439 445 O
increase 105 113 446 454 O
the 114 117 455 458 O
risk 118 122 459 463 O
to 123 125 464 466 O
the 126 129 467 470 O
patient 130 137 471 478 O
beyond 138 144 479 485 O
what 145 149 486 490 O
is 150 152 491 493 O
to 153 155 494 496 O
be 156 158 497 499 O
expected 159 167 500 508 O
from 168 172 509 513 O
standard 173 181 514 522 O
procedures 182 192 523 533 O
of 193 195 534 536 O
intraocular 196 207 537 548 B-treatment
injection 208 217 549 558 I-treatment
, 217 218 558 559 O
or 219 221 560 562 O
which 222 227 563 568 O
otherwise 228 237 569 578 O
may 238 241 579 582 O
interfere 242 251 583 592 O
with 252 256 593 597 O
the 257 260 598 601 O
injection 261 270 602 611 O
procedure 271 280 612 621 O
or 281 283 622 624 O
with 284 288 625 629 O
evaluation 289 299 630 640 O
of 300 302 641 643 O
efficacy 303 311 644 652 O
or 312 314 653 655 O
safety 315 321 656 662 O

Central 0 7 663 670 B-clinical_variable
subfield 8 16 671 679 I-clinical_variable
macular 17 24 680 687 I-clinical_variable
thickness 25 34 688 697 I-clinical_variable
≤ 35 36 698 699 O
320 37 40 700 703 B-upper_bound
μm 41 43 704 706 I-upper_bound
in 44 46 707 709 O
the 47 50 710 713 O
study 51 56 714 719 O
eye 57 60 720 723 O
prior 61 66 724 729 O
to 67 69 730 732 O
cataract 70 78 733 741 B-treatment
surgery 79 86 742 749 I-treatment
as 87 89 750 752 O
determined 90 100 753 763 O
by 101 103 764 766 O
SD 104 106 767 769 O
- 106 107 769 770 O
OCT 107 110 770 773 O
and 111 114 774 777 O
confirmed 115 124 778 787 O
by 125 127 788 790 O
the 128 131 791 794 O
reading 132 139 795 802 O
center 140 146 803 809 O

Current 0 7 810 817 O
or 8 10 818 820 O
previous 11 19 821 829 O
ocular 20 26 830 836 B-chronic_disease
disease 27 34 837 844 I-chronic_disease
in 35 37 845 847 O
the 38 41 848 851 O
study 42 47 852 857 O
eye 48 51 858 861 O
that 52 56 862 866 O
in 57 59 867 869 O
the 60 63 870 873 O
opinion 64 71 874 881 O
of 72 74 882 884 O
the 75 78 885 888 O
investigator 79 91 889 901 O
may 92 95 902 905 O
confound 96 104 906 914 O
assessment 105 115 915 925 O
of 116 118 926 928 O
the 119 122 929 932 O
macula 123 129 933 939 O
, 129 130 939 940 O
the 131 134 941 944 O
retina 135 141 945 951 O
, 141 142 951 952 O
or 143 145 953 955 O
central 146 153 956 963 O
vision 154 160 964 970 O
other 161 166 971 976 O
that 167 171 977 981 O
diabetic 172 180 982 990 B-chronic_disease
retinopathy 181 192 991 1002 I-chronic_disease

Focal 0 5 1003 1008 B-treatment
photocoagulation 6 22 1009 1025 I-treatment
for 23 26 1026 1029 O
the 27 30 1030 1033 O
treatment 31 40 1034 1043 B-treatment
of 41 43 1044 1046 O
diabetic 44 52 1047 1055 B-chronic_disease
macular 53 60 1056 1063 I-chronic_disease
edema 61 66 1064 1069 I-chronic_disease
in 67 69 1070 1072 O
the 70 73 1073 1076 O
study 74 79 1077 1082 O
eye 80 83 1083 1086 O
within 84 90 1087 1093 O
6 91 92 1094 1095 B-upper_bound
months 93 99 1096 1102 I-upper_bound
of 100 102 1103 1105 O
the 103 106 1106 1109 O
pre 107 110 1110 1113 O
- 110 111 1113 1114 O
operative 111 120 1114 1123 O
baseline 121 129 1124 1132 O
visit 130 135 1133 1138 O

History 0 7 1139 1146 O
of 8 10 1147 1149 O
Type 11 15 1150 1154 B-lower_bound
I 16 17 1155 1156 I-lower_bound
or 18 20 1157 1159 O
Type 21 25 1160 1164 B-upper_bound
II 26 28 1165 1167 I-upper_bound
diabetes 29 37 1168 1176 I-upper_bound

Intravitreal 0 12 1177 1189 B-treatment
anti 13 17 1190 1194 I-treatment
- 17 18 1194 1195 I-treatment
VEGF 18 22 1195 1199 I-treatment
( 23 24 1200 1201 I-treatment
vascular 24 32 1201 1209 I-treatment
endothelial 33 44 1210 1221 I-treatment
growth 45 51 1222 1228 I-treatment
factor 52 58 1229 1235 I-treatment
) 58 59 1235 1236 I-treatment
treatment 60 69 1237 1246 I-treatment
in 70 72 1247 1249 O
the 73 76 1250 1253 O
study 77 82 1254 1259 O
eye 83 86 1260 1263 O
within 87 93 1264 1270 O
6 94 95 1271 1272 B-upper_bound
months 96 102 1273 1279 I-upper_bound
of 103 105 1280 1282 O
the 106 109 1283 1286 O
pre 110 113 1287 1290 O
- 113 114 1290 1291 O
operative 114 123 1291 1300 O
baseline 124 132 1301 1309 O
visit 133 138 1310 1315 O

Must 0 4 1316 1320 O
be 5 7 1321 1323 O
18 8 10 1324 1326 B-lower_bound
years 11 16 1327 1332 I-lower_bound
of 17 19 1333 1335 O
age 20 23 1336 1339 B-age
and 24 27 1340 1343 O
older 28 33 1344 1349 O

NPDR 0 4 1350 1354 B-chronic_disease
: 4 5 1354 1355 I-chronic_disease
non 6 9 1356 1359 I-chronic_disease
- 9 10 1359 1360 I-chronic_disease
proliferative 10 23 1360 1373 I-chronic_disease
diabetic 24 32 1374 1382 I-chronic_disease
retinopathy 33 44 1383 1394 I-chronic_disease
( 45 46 1395 1396 O
mild 46 50 1396 1400 O
, 50 51 1400 1401 O
moderate 52 60 1402 1410 O
, 60 61 1410 1411 O
or 62 64 1412 1414 O
severe 65 71 1415 1421 O
) 71 72 1421 1422 O
or 73 75 1423 1425 O
inactive 76 84 1426 1434 O
proliferative 85 98 1435 1448 B-chronic_disease
disease 99 106 1449 1456 I-chronic_disease
in 107 109 1457 1459 O
the 110 113 1460 1463 O
study 114 119 1464 1469 O
eye 120 123 1470 1473 O
as 124 126 1474 1476 O
defined 127 134 1477 1484 O
by 135 137 1485 1487 O
the 138 141 1488 1491 O
International 142 155 1492 1505 B-clinical_variable
Clinical 156 164 1506 1514 I-clinical_variable
Diabetic 165 173 1515 1523 I-clinical_variable
Retinopathy 174 185 1524 1535 I-clinical_variable
Disease 186 193 1536 1543 I-clinical_variable
Severity 194 202 1544 1552 I-clinical_variable
Scale 203 208 1553 1558 I-clinical_variable

Patients 0 8 1559 1567 O
must 9 13 1568 1572 O
have 14 18 1573 1577 O
visual 19 25 1578 1584 B-clinical_variable
acuity 26 32 1585 1591 I-clinical_variable
of 33 35 1592 1594 O
20/20 36 41 1595 1600 B-lower_bound
- 41 42 1600 1601 O
20/200 42 48 1601 1607 B-upper_bound

Patients 0 8 1608 1616 O
who 9 12 1617 1620 O
are 13 16 1621 1624 O
immunocompromised 17 34 1625 1642 B-chronic_disease
( 35 36 1643 1644 O
e.g. 36 40 1644 1648 O
, 40 41 1648 1649 O
patients 42 50 1650 1658 O
receiving 51 60 1659 1668 O
chemotherapy 61 73 1669 1681 B-treatment
irradiation 74 85 1682 1693 B-treatment
therapy 86 93 1694 1701 I-treatment
, 93 94 1701 1702 O
patients 95 103 1703 1711 O
with 104 108 1712 1716 O
AIDS 109 113 1717 1721 B-chronic_disease
, 113 114 1721 1722 O
leukemia 115 123 1723 1731 B-chronic_disease
, 123 124 1731 1732 O
or 125 127 1733 1735 O
cachexia 128 136 1736 1744 B-chronic_disease
) 136 137 1744 1745 O
or 138 140 1746 1748 O
patients 141 149 1749 1757 O
receiving 150 159 1758 1767 O
dialysis 160 168 1768 1776 B-treatment

Patients 0 8 1777 1785 O
who 9 12 1786 1789 O
have 13 17 1790 1794 O
received 18 26 1795 1803 O
corneal 27 34 1804 1811 B-treatment
transplants 35 46 1812 1823 I-treatment
in 47 49 1824 1826 O
the 50 53 1827 1830 O
study 54 59 1831 1836 O
eye 60 63 1837 1840 O

Patients 0 8 1841 1849 O
with 9 13 1850 1854 O
a 14 15 1855 1856 O
known 16 21 1857 1862 O
hypersensitivity 22 38 1863 1879 O
to 39 41 1880 1882 O
NSAIDs 42 48 1883 1889 B-allergy_name
or 49 51 1890 1892 O
steroids 52 60 1893 1901 B-allergy_name
or 61 63 1902 1904 O
any 64 67 1905 1908 O
component 68 77 1909 1918 O
of 78 80 1919 1921 O
the 81 84 1922 1925 O
study 85 90 1926 1931 O
medication 91 101 1932 1942 B-treatment

Patients 0 8 1943 1951 O
with 9 13 1952 1956 O
current 14 21 1957 1964 O
or 22 24 1965 1967 O
history 25 32 1968 1975 O
of 33 35 1976 1978 O
chronic 36 43 1979 1986 O
or 44 46 1987 1989 O
recurrent 47 56 1990 1999 O
ocular 57 63 2000 2006 B-chronic_disease
infections 64 74 2007 2017 I-chronic_disease
or 75 77 2018 2020 O
inflammation 78 90 2021 2033 B-chronic_disease
in 91 93 2034 2036 I-chronic_disease
the 94 97 2037 2040 I-chronic_disease
study 98 103 2041 2046 I-chronic_disease
eye 104 107 2047 2050 I-chronic_disease

Planned 0 7 2051 2058 O
multiple 8 16 2059 2067 O
procedures 17 27 2068 2078 O
for 28 31 2079 2082 O
study 32 37 2083 2088 O
eye 38 41 2089 2092 O
during 42 48 2093 2099 O
the 49 52 2100 2103 O
cataract 53 61 2104 2112 B-treatment
/ 61 62 2112 2113 I-treatment
IOL 62 65 2113 2116 I-treatment
implantation 66 78 2117 2129 I-treatment
surgery 79 86 2130 2137 I-treatment
( 87 88 2138 2139 O
e.g. 88 92 2139 2143 O
, 92 93 2143 2144 O
trabeculectomy 94 108 2145 2159 B-treatment
, 108 109 2159 2160 O
corneal 110 117 2161 2168 B-treatment
transplant 118 128 2169 2179 I-treatment
) 128 129 2179 2180 O

Pregnant 0 8 2181 2189 B-pregnancy

Signs 0 5 2190 2195 O
of 6 8 2196 2198 O
vitreomacular 9 22 2199 2212 B-chronic_disease
traction 23 31 2213 2221 I-chronic_disease
or 32 34 2222 2224 O
epiretinal 35 45 2225 2235 B-chronic_disease
membrane 46 54 2236 2244 I-chronic_disease
in 55 57 2245 2247 O
the 58 61 2248 2251 O
study 62 67 2252 2257 O
eye 68 71 2258 2261 O

Treatment 0 9 2262 2271 B-treatment
with 10 14 2272 2276 O
intraocular 15 26 2277 2288 B-treatment
or 27 29 2289 2291 O
periocular 30 40 2292 2302 B-treatment
steroids 41 49 2303 2311 I-treatment
in 50 52 2312 2314 O
the 53 56 2315 2318 O
study 57 62 2319 2324 O
eye 63 66 2325 2328 O
within 67 73 2329 2335 O
3 74 75 2336 2337 B-upper_bound
months 76 82 2338 2344 I-upper_bound
prior 83 88 2345 2350 I-upper_bound
to 89 91 2351 2353 O
surgery 92 99 2354 2361 B-treatment

Use 0 3 2362 2365 O
of 4 6 2366 2368 O
a 7 8 2369 2370 O
topical 9 16 2371 2378 B-treatment
ophthalmic 17 27 2379 2389 I-treatment
prostaglandin 28 41 2390 2403 I-treatment
( 42 43 2404 2405 O
e.g. 43 47 2405 2409 O
, 47 48 2409 2410 O
TRAVATAN 49 57 2411 2419 B-treatment
, 57 58 2419 2420 O
XALATAN 59 66 2421 2428 B-treatment
) 66 67 2428 2429 O
within 68 74 2430 2436 O
4 75 76 2437 2438 B-upper_bound
days 77 81 2439 2443 I-upper_bound
of 82 84 2444 2446 O
surgery 85 92 2447 2454 B-treatment
through 93 100 2455 2462 O
study 101 106 2463 2468 O
exit 107 111 2469 2473 O

Use 0 3 2474 2477 O
of 4 6 2478 2480 O
medications 7 18 2481 2492 B-treatment
known 19 24 2493 2498 O
to 25 27 2499 2501 O
affect 28 34 2502 2508 O
the 35 38 2509 2512 O
macula 39 45 2513 2519 O
, 45 46 2519 2520 O
including 47 56 2521 2530 O
hydroxychloroquinine 57 77 2531 2551 B-treatment
( 78 79 2552 2553 I-treatment
Plaquenil 79 88 2553 2562 I-treatment
) 88 89 2562 2563 I-treatment
and 90 93 2564 2567 O
phenothiozines 94 108 2568 2582 B-treatment
( 109 110 2583 2584 O
e.g. 110 114 2584 2588 O
, 114 115 2588 2589 O
thioridazine 116 128 2590 2602 B-treatment
[ 129 130 2603 2604 I-treatment
Mellaril 130 138 2604 2612 I-treatment
] 138 139 2612 2613 I-treatment
, 139 140 2613 2614 O
chloropromazine 141 156 2615 2630 B-treatment
[ 157 158 2631 2632 I-treatment
Thorazine 158 167 2632 2641 I-treatment
] 167 168 2641 2642 I-treatment
) 168 169 2642 2643 O
or 170 172 2644 2646 O
supplemental 173 185 2647 2659 O
niacin 186 192 2660 2666 B-treatment
≥3 193 195 2667 2669 O
grams 196 201 2670 2675 I-lower_bound
/ 201 202 2675 2676 I-lower_bound
day 202 205 2676 2679 I-lower_bound

Use 0 3 2680 2683 O
of 4 6 2684 2686 O
systemic 7 15 2687 2695 B-treatment
steroids 16 24 2696 2704 I-treatment
, 24 25 2704 2705 O
NSAIDS 26 32 2706 2712 B-treatment
( 33 34 2713 2714 O
non 34 37 2714 2717 B-treatment
- 37 38 2717 2718 I-treatment
steroidal 38 47 2718 2727 I-treatment
anti 48 52 2728 2732 I-treatment
- 52 53 2732 2733 I-treatment
inflammatory 53 65 2733 2745 I-treatment
drugs 66 71 2746 2751 I-treatment
) 71 72 2751 2752 O
, 72 73 2752 2753 O
anti 74 78 2754 2758 B-treatment
- 78 79 2758 2759 I-treatment
VEGF 79 83 2759 2763 I-treatment
agents 84 90 2764 2770 I-treatment
within 91 97 2771 2777 O
7 98 99 2778 2779 B-upper_bound
days 100 104 2780 2784 I-upper_bound
prior 105 110 2785 2790 I-upper_bound
to 111 113 2791 2793 O
surgery 114 121 2794 2801 B-treatment
( 122 123 2802 2803 O
through 123 130 2803 2810 O
study 131 136 2811 2816 O
exit 137 141 2817 2821 O
) 141 142 2821 2822 O
. 142 143 2822 2823 O
Daily 144 149 2824 2829 O
doses 150 155 2830 2835 O
of 156 158 2836 2838 O
aspirin 159 166 2839 2846 B-treatment
, 166 167 2846 2847 O
up 168 170 2848 2850 O
to 171 173 2851 2853 O
325 174 177 2854 2857 B-upper_bound
mg 178 180 2858 2860 I-upper_bound
, 180 181 2860 2861 O
will 182 186 2862 2866 O
be 187 189 2867 2869 O
permitted 190 199 2870 2879 O

Use 0 3 2880 2883 O
of 4 6 2884 2886 O
topical 7 14 2887 2894 O
ocular 15 21 2895 2901 O
NSAIDS 22 28 2902 2908 B-treatment
and 29 32 2909 2912 O
steroids 33 41 2913 2921 B-treatment
, 41 42 2921 2922 O
in 43 45 2923 2925 O
the 46 49 2926 2929 O
study 50 55 2930 2935 O
eye 56 59 2936 2939 O
, 59 60 2939 2940 O
within 61 67 2941 2947 O
7 68 69 2948 2949 B-upper_bound
days 70 74 2950 2954 I-upper_bound
prior 75 80 2955 2960 I-upper_bound
to 81 83 2961 2963 O
surgery 84 91 2964 2971 B-treatment

and 0 3 2972 2975 O
are 4 7 2976 2979 O
planning 8 16 2980 2988 O
to 17 19 2989 2991 O
undergo 20 27 2992 2999 O
cataract 28 36 3000 3008 B-treatment
extraction 37 47 3009 3019 I-treatment
by 48 50 3020 3022 O
phacoemulsification 51 70 3023 3042 B-treatment
with 71 75 3043 3047 O
the 76 79 3048 3051 O
implantation 80 92 3052 3064 O
of 93 95 3065 3067 O
a 96 97 3068 3069 O
posterior 98 107 3070 3079 O
chamber 108 115 3080 3087 O
intraocular 116 127 3088 3099 O
lens 128 132 3100 3104 O
into 133 137 3105 3109 O
the 138 141 3110 3113 O
lens 142 146 3114 3118 O
capsule 147 154 3119 3126 O

breast 0 6 3127 3133 O
- 6 7 3133 3134 O
feeding 7 14 3134 3141 O
women 15 20 3142 3147 B-gender

peripheral 0 10 3148 3158 B-treatment
retina 11 17 3159 3165 I-treatment
treatment 18 27 3166 3175 I-treatment
for 28 31 3176 3179 O
retinal 32 39 3180 3187 B-chronic_disease
tear 40 44 3188 3192 I-chronic_disease
or 45 47 3193 3195 O
lattice 48 55 3196 3203 B-chronic_disease
degeneration 56 68 3204 3216 I-chronic_disease

who 0 3 3217 3220 O
have 4 8 3221 3225 O
a 9 10 3226 3227 O
cataract 11 19 3228 3236 B-chronic_disease

